Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDXQ)

CUSIP: 00430H201

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
25,187,879
Total 13F shares
4,106,069
Share change
-286,798
Total reported value
$2,875,905
Put/Call ratio
2%
Price per share
$0.70
Number of holders
41
Value change
-$238,366
Number of buys
8
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 00430H201?
CUSIP 00430H201 identifies AXDXQ - Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDXQ) as of Q1 2025

As of 31 Mar 2025, Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDXQ) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,106,069 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, GRIFFIN ASSET MANAGEMENT, INC., VANGUARD GROUP INC, Lido Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, Cannell & Spears LLC, RENAISSANCE TECHNOLOGIES LLC, TCI Wealth Advisors, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BlackRock, Inc.. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.